|
|
|
|
|
|
|
|
||
![]() |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|||||||
![]() |
|
|
LinkBack | Thread Tools | Display Modes |
|
||||
|
"Mast Cell Activation Syndrome" may lie at the core of some vascular rosacea sufferers: Excellent article by Dr. Hamilton and colleagues of Harvard
A new flushing and facial redness disorder has been identified in 2011 as "Mast Cell Activation Syndrome". This is not Mastocytosis, it does not involve an allergic response and it does not require mast cell bumps to show up on the skin. It is simply a disorder where mast cells throughout the skin and GI tract are "leaky" and prone to release their many inflammatory substances. In the article below it tells patients what to look for and if the symptoms are present, mast cell blockers and mast cell membrane stabilizers may clear the condition... For anyone with these symptoms an Allergist or Endocrinologist are the specialists to see.... J Allergy Clin Immunol. 2011 May 26. Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations. Hamilton MJ, Hornick JL, Akin C, Castells MC, Greenberger NJ. SourceDepartment of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. BACKGROUND: Diagnostic criteria for mast cell (MC) activation syndrome have been recently proposed, but clinical studies to validate these criteria are lacking. OBJECTIVE: We sought to determine the clinical manifestations of this newly recognized syndrome in a cohort of patients. METHODS: We prospectively evaluated 18 patients seen at our institution with MC activation syndrome from 2006 to 2009. Patients enrolled had at least 4 of the signs and symptoms of abdominal pain, diarrhea, flushing, dermatographism, memory and concentration difficulties, or headache. Response to treatment with anti-MC mediator medications was assessed based on established criteria. Laboratory tests indicating MC mediator release and histopathology and immunohistochemical studies on gastrointestinal biopsy samples were performed. RESULTS: Ninety-four percent of the patients had abdominal pain, 89% had dermatographism, 89% had flushing, and 72% had the constellation of all 3 symptoms. Patients additionally had headache, diarrhea, and memory and concentration difficulties. All patients had at least 1 positive laboratory test result for an increased MC mediator level. On the basis of the response to treatment criteria, 67% of the patients in the cohort had either a complete or major regression in symptoms while taking medications targeting MC mediators. There was no significant difference in the numbers of intestinal mucosal MCs between our patients and healthy control subjects. CONCLUSION: MC activation syndrome might be the underlying cause of unexplained flushing symptoms when several organ systems are involved, such as the gastrointestinal tract and the skin. It is especially important to be able to recognize the constellation of clinical features because response to anti-MC mediator medications is often excellent.
__________________
_ Best, Geoffrey Dr. Geoffrey Nase Ph.D: Neuro-Vascular Physiologist Email: drnase1000@hotmail.com Bibliography: http://drnase.com All posts are for informational purposes only. Please visit our Home Page to view our Medical Disclaimer. |
|
||||
|
Quote:
Good luck and please keep us posted because up to 30% of rosacea sufferers could be helped by mast cell stabilizers which are generally inert medications that should show an effect in under two weeks. Worth the trial for many. __
__________________
_ Best, Geoffrey Dr. Geoffrey Nase Ph.D: Neuro-Vascular Physiologist Email: drnase1000@hotmail.com Bibliography: http://drnase.com All posts are for informational purposes only. Please visit our Home Page to view our Medical Disclaimer. |
![]() |
| Thread Tools | |
| Display Modes | |
|
|